DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Friday 23 January 2015

Wilma Lukas

Wilma Lukas, PhD, MBA

Founder & Managing Director at W Life Sciences - Expert Board at Skolkovo Foundation

Dr Lukas has over 20 years of experience in drug discovery, R&D, licensing and business development. Ph.D. in Biology from the Universtity of Geneva, completed by an MBA, she gained pharmaceutical expertise at the Glaxo Institute (GSK) and Serono (now Merck Serono) before joining a start-up that was later on successfully acquired byMolecular Devices Corp (USA).

Dr Lukas joined Debiopharm in 2007. She was in charge of the search and evaluation process and identified pre-clinical and clinical opportunities to in-license in line with Debiopharm’s strategy, business model and portfolio.

Dr Lukas has created her own consultancy (W Life Sciences) to provide strategic advices and expert scientific opinion to biotech companies, start-ups, universities, investors or pharmaceutical companies. She is supported by expert advisors with more than twenty years of experience in business development and clinical development.

http://www.wlifesciences.com/

http://www.wlifesciences.com/about/

ch.linkedin.com/in/wilmalukas

Summary

* PhD, MBA, over twenty years experience in the pharmaceutical industry (GSK, Merck Serono, Debiopharm, Molecular Devices)

* Business development, Licensing, Drug Discovery, R&D and Drug Development expertise

Experience

Founder & Managing Director

W Life Sciences

2013 – Present Geneva Area, Switzerland

- In Licensing: search and identify innovative opportunities
- Out Licensing: search and identify potential partners
- Fund raising
- Mentoring early-stage biotech / start-up companies
- Interim / Part-time business development
- Strategy and positionning
- Market and competition analysis
- Due diligence
- Valuation

- Evaluation of > 1000s opportunities
- All major therapeutic areas, small molecules, biologics, diagnostics

www.wlifesciences.com

Expert Board

Skolkovo Foundation

2015 – Present (less than a year)Geneva Area, Switzerland

Senior S&E Officer, in Licensing - PhD, MBA

Debiopharm

July 2010 – 2013 (3 years)

Drive search and evaluation process of new product opportunities
Identify preclinical and clinical licensing opportunities and companion diagnostics in alignment with company portfolio strategy
Participate and present at international partnering and investor conferences
Discover new areas of innovation and growth opportunities
Perform competitive intelligence and monitor the business environment
Strong network within biotechs, pharmaceutical companies, start-ups, technology transfer centers, bioclusters, science parks, venture capital companies, brokers or governmental organizations

Senior Prospector, PhD, MBA

Debiopharm

2007 – July 2010 (3 years)Switzerland

Drive search and evaluation process of new product opportunities
Identify preclinical and clinical licensing opportunities and companion diagnostics in alignment with company portfolio strategy

Biotech & Pharma Consultant

-

2004 – 2007 (3 years)

Expertise in Life Sciences, Pharma, New Technologies, Biomedical Devices
Provide scientific support in project evaluation and strategy

Group Leader Biology

Molecular Devices (Cytion)

2001 – 2003 (2 years)

Development of a new drug screening technology (HTS) for the pharmaceutical industry and academia
Managerial experience in a multicultural environment

Scientist

Merck Serono

1998 – 2001 (3 years)

Drug discovery and development
Managed cross-functional team in multinational environment

Ass. Scientist

GlaxoSmithKline

1989 – 1997 (8 years)

R&D in Neurobiology, Physiology, Immunology, Molecular Biology, Biochemistry, Ion channel-related diseases.
Projects management
Scientific publications

Organizations

Swiss HLG (Pharma Licensing Group)

Member

May 2014 – Present

HBA (Healthcare Businesswomen's Association)

Member

2014 – Present

Geneva Pharma Network

Member

2013 – Present

G.E.I. (Gruppo Esponenti Italiani)

Member

January 2013 – Present

Lausanne, Switzerland

Trevisani nel Mondo

President, Lausanne, Switzerland

January 1992 – Present

Education

University of Geneva

Ph.D., Biological Sciences

1995 – 1999

Ph.D. thesis with honors
Two pores potassium channel: structure and function study

IFCAM

Master of Business Administration (MBA)

2003 – 2004

• Finance
• Accounting
• Law
• Marketing
• Production
• Human Resources
• General Business Administration

Université de Lausanne

MSc Biology

1979 – 1984

W Life Sciences facilitates strategic relationships, provides advisory services in business development, licensing activities and evaluation of opportunities

Identifying innovation and boosting promissing drug candidates is a must

W Life sciences is an independent consulting firm based in Switzerland

Wilma Lukas, PhD, MBA

Managing Director

W Life Sciences

1260 Nyon - Switzerland

Mobile: +41 (0) 79 362 51 91

www.wlifesciences.com

lusanne....below

Skolkovo Foundation

Skolkovo Foundation FIRST ACHIEVEMENTS. 2010—2011Creatingin Skolkovo The foundation expert network: Berkley, Russian and International Skolkovo Innovation ...